|

Regorafenib Pill Clinical Trials

1 actively recruiting trial across 1 location

Also known as: STIVARGA

Pipeline

Phase 2: 1

Top Sponsors

  • Teclison Ltd.1

Indications

  • Liver Disease1
  • Colorectal Cancer; Lung Cancer1
  • Liver Cancer1
  • Lung Cancer1
  • Cancer1

Orange, California1 trial

TATE and Pembrolizumab (MK3475) in mCRC and NSCLC

University of California, Irvine Medical Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.